Coronary Artery Disease

Results of the OPTIMIZE trial presented

A new study demonstrates that some patients may not need to receive prolonged anti-clotting therapy after drug-eluting stent (DES) implantation with the Endeavor zotarolimus-eluting stent, and that shortening the duration ...

Oct 31, 2013
popularity not rated yet | comments 0

Results of the ADVISE II trial presented

A new study supports the use of instantaneous wave-free ratio (iFR), to simplify assessment and determine the severity of coronary artery disease. ADVISE II findings were presented today at the 25th annual Transcatheter Cardiovascular ...

Oct 30, 2013
popularity not rated yet | comments 0

Results of the SORT-OUT VI trial presented

A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible ...

Oct 30, 2013
popularity not rated yet | comments 0

Latest Spotlight News

Man among first in US to get 'bionic eye' (Update)

A degenerative eye disease slowly robbed Roger Pontz of his vision. Diagnosed with retinitis pigmentosa as a teenager, Pontz has been almost completely blind for years. Now, thanks to a high-tech procedure ...

Deliberation is staunchest ally of selfishness

(Medical Xpress)—Over the last two years, Yale psychologist David Rand and colleagues have investigated what makes people willing to help each other. Their latest research shows that while initial reactions ...

Cyber buddy is better than 'no buddy'

A Michigan State University researcher is looking to give exercise enthusiasts the extra nudge they need during a workout, and her latest research shows that a cyber buddy can help.

Touch influences how infants learn language

(Medical Xpress)—Tickling a baby's toes may be cute but it's also possible that those touches could help babies learn the words in their language. Research from Purdue University shows that a caregiver's ...